Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance

por Imeri, Jusuf, Desterke, Christophe, Marcoux, Paul, Chaker, Diana, Oudrhiri, Noufissa, Fund, Xavier, Faivre, Jamila, Bennaceur-Griscelli, Annelise, Turhan, Ali G.
Publicado 2023